Key Takeaways:

• In the first quarter of 2024, the U.S. life sciences sector raised $10.7 billion in venture capital from over 700 deals, with two notable ventures each securing over $400 million in investment.
• Many life sciences companies continue to strategically manage their real estate portfolios to cut operational costs, leading to a sustained increase in sublease space availability.
• As the market evolves, landlords are adapting by building lab spaces speculatively, enabling them to effectively compete with the growing volume of sublease space available.